Anthony Feinstein is a professor of Psychiatry at the University of Toronto and past Chair of the Medical Advisory Committee of the MS Society of Canada. His MS research has focused on determining cerebral correlates of depression and disorders of affect, the use of computers and distracters in eliciting cognitive dysfunction, and the behavioral effects of cannabis and the mechanisms underlying these behaviours. He is currently lead investigator on the CogEx trail, a six-country study determining the efficacy of treating cognitive impairment in people with progressive MS using high intensity aerobic exercise and cognitive rehabilitation. In 2023, he was honored with a ““Giants of MS” award from the Consortium of MS Centres and Neurology Live.